This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,765.70 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on October 16, 2024 and has an ultimate completion date of November 6, 2024. The contract is for the delivery of 4,566,150,192 units of the oncology medication ONCASPAR in 5 mL vials. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military healthcare facilities worldwide. This specific award does not have a set-aside designation.
Generated 1/15/25, 9:29 AM